Conditions & Recovery · NY Times Health · September 30, 2026

New Cancer Drugs Are Revolutionary. Why Don’t More Patients Get Them?

Targeted gene therapies are highly effective at stopping cancers, but the very abundance of the treatments, plus cost and sluggish change, are hindering access.

Originally published by NY Times Health. We curate and add context; they did the reporting.

Read the full story at NY Times Health ↗

Related learning

Biotech Firm Claims Some Credit for Groundbreaking Virus Research Biotech Firm Claims Some Credit for Groundbreaking Virus Research James P. Allison, Ph.D., bangs gong after completing proton therapy treatment Combination therapy helps plasmacytoid bladder cancer survivor